|
|
|
|
|
04.11.26 - 15:06
|
Insulet Q3 Net Income Rises; Issues FY26 Outlook (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Insulet (PODD) reported third quarter net income of $141.1 million, or $2.03 per diluted share, compared to $87.6 million, or $1.24 per diluted share, prior year. Adjusted n......
|
|
|
|
|
04.11.26 - 13:03
|
Insulet Reports Third Quarter 2026 Results (Business Wire)
|
|
|
Third Quarter Revenue of $842 million, Increase of 19.2% (19.6% in Constant Currency1)ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results for the three months ended September 30, 2026.
Third Quarter Financial Highlights:
Revenue of $842.0 million, up 19.2%, or 19.6% in constant currency, slightly above the high end of the Company's guidance range of 17.5% - 19.5% at constant currency rates
Total Omnipod revenue of $836.6 million, rose 19.7%, or 20.0% in constant currency
U.S. Omnipod revenue of $570.4 million, increased 14.7%
International Omnipod revenue of $266.2 million, increased 31.7%, or 33.0% in constant currency
Drug Delivery revenue of $5.5 million
Operating income of $189.8 million, or 22.5% of revenue, up 590 basis points over prior year
Adjusted operating income1 of $185.2 million, or 22.0% of revenue, up 490 basis points com...
|
|
|
|
|
01.10.26 - 13:06
|
Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026 (Business Wire)
|
|
|
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financial results for the third quarter of 2026 on Wednesday, November 4, 2026, before the opening of the financial markets. In connection with the release, management will host a conference call that day at 8:00 a.m. (Eastern Time).
The link to the live call will be available on the Investor Relations section of the Company's website at investors.insulet.com, “Events and Presentations,” and will be archived for future replay. You may also access the live call by dialing (833) 461-5787 for domestic callers, or (585) 542-9983 for international callers; the passcode is 186 295 579.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions th...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
